A detailed history of Brave Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brave Asset Management Inc holds 6,400 shares of BMY stock, worth $370,432. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,400
Holding current value
$370,432
% of portfolio
0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$39.66 - $51.75 $253,823 - $331,200
6,400 New
6,400 $331,000
Q2 2023

Jul 24, 2023

BUY
$63.71 - $70.74 $4,459 - $4,951
70 Added 1.96%
3,639 $232,000
Q1 2023

Apr 12, 2023

SELL
$65.71 - $74.53 $5,913 - $6,707
-90 Reduced 2.46%
3,569 $247,000
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 2.66%
3,659 $217,000
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $17,802 - $20,022
-300 Reduced 7.39%
3,759 $237,000
Q4 2020

Jan 27, 2021

BUY
$57.74 - $65.43 $234,366 - $265,580
4,059 New
4,059 $252,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.